Abstract:Objective To explore the surgical characteristics of primary tracheal tumors treatment and its prognosis. Methods We retrospectively investigated the clinical records of 38 patients with primary tracheal tumors in both Xiangya Hospital of Central South University and Hunan Provincial Tumor Hospital from Febuary 1982 to August 2009.There were 24 males and 14 females aged from 7 to 65 years.There were 2 benign lesions,13 adenoid cystic carcinomas,11 squamous cell carcinomas,5 mucoepidermoid carcinomas,4 adenocarcinomas and 3 other cell types.One patient with adenocarcinoma underwent exploratory thoracotomy only;33 patients underwent tracheal resection and airway reconstruction,and according to the tumor growth characteristics,the surgeon applied circumferential tracheal resection with end-to-end anostomosis or wedge resection;One patient had papilloma resected under fiber bronchoscopy;and three patients with locally advanced lesions underwent radiotherapy without surgery.The overall survival rate was calculated by the Kaplan-Meier method.The log-rank method was used for comparing survival rates among different groups,characterized by cell types or surgical procedures. Results The patient with exploratory thoracotomy died 3 days after surgery from respiratory failure.The perioperative mortality was 2.94%(1/34),and all the remaining 33 patients recovered and were discharged from hospital.Minor complications happened to 12 patients(35.29%),including 6 patients with pulmonary infection,4 with atelectasis,and 2 with hoarseness.The follow-up time ranged from 6 months to 15 years.The follow-up rate was 97.29%(36/37).The three unresected patients died within 6 months after hospital discharge.The 1,5,and 10-year survival rate for resected patients was88%(95%CI 0.77 to 0.99),47%(95%CI 0.29 to 0.66),and 41%(95%CI 0.21 to 0.61),respectively.The survival rate of adenoid cystic carcinoma or mucoepidermoid carcinoma was significantly higher than that of squamous cell carcinoma or other tissue types(χ2=17.581,P=0.001).There was no statistical difference(χ2=0.021,P=0.886) in 5-year survival rate between wedge resection group at 63%(95%CI 0.34 to 0.91) and the segmental resection group at 77%(95%CI 0.44 to 0.99).Conclusions Surgical treatment is safe and beneficial for primary tracheal tumors,and the pathological type is a significant prognostic factor after complete resection.

Surgical Treatment of the Primary Tracheal and Carinal Tumors

[Surgical treatment of primary malignant tumors of the trachea and main bronchus]

Treatment for Patients with Primary Tracheal Tumors

[Tracheal and carinal resection and reconstruction in the treatment of lung cancer]

Clinical application of surgical resection of tracheal tumor and airway reconstruction

Treatment of 40 patients with primary tracheal carcinoma

[The long-term outcome and prognostic analysis of surgically treated patients with trachea tumors]

Primary Small Cell Cancer of Cervical Trachea: A Case Report and Literature Review

Clinical experience on surgical treatment of tracheal diseases

The Surgical Treatment of Malignant Tracheal Tumor

Resected Tracheal Adenoid Cystic Carcinoma: Improvements in Outcome at a Single Institution

Tracheal sleeve pneumonectomy for bronchogenic carcinoma invading the carina

Clinical characteristics, surgical treatments, prognosis, and prognostic factors of primary tracheal cancer patients: 20-year data of the National Cancer Center, China

Tracheal Carina Reconstruction and Bronchoplasty in the Treatment of 94 Central Type Bronchogenic Carcinomas

Primary Carcinomas of the Trachea: Natural History, Treatment and Results

[Surgical Management of Primary Cervical Tracheal Cancer].

Clinical Experience in Treatment of Primary Tracheal Adenoid Cystic Carcinoma

Resection of the Tracheobronchial Bifurcation With Complete Preservation of Lung Parenchyma

Surgical Treatment of Primary Tracheobronchial Tumors: 16-Year Experience in a Single Center

Tracheal sleeve pneumonectomy for non small cell lung cancer (NSCLC): short and long-term results in a single institution

[Perioperative management for primary tracheal malignant tumors resected under cardiopulmonary bypass]